Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Queens University Belfast
University Road
Belfast
BT7 1NN
UK
Contact person: Shauna Ryan
E-mail: Shauna.Ryan@qub.ac.uk
NUTS: UKN06
Internet address(es)
Main address: www.qub.ac.uk
Address of the buyer profile: https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
QUB/2485/23 Contract for for a Compact Multi-modal and Multi-scale Retinal Imaging System
Reference number: QUB/2485/23
II.1.2) Main CPV code
33110000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Multiple research groups within QUB are addressing the earliest changes of disease at the complex intersection between normal ageing and early pathology in AMD (Peto, Hogg, Lengyel), Diabetic Retinopathy (Peto, Stitt, Lois, Hogg, Curtis) and Glaucoma (Azuara-Blanco and Hogg), exploring interventions to delay or prevent onset. Cutting edge retinal imaging is crucial to these endeavours. Advanced retinal imaging has been at the forefront of research advances in ophthalmology; as resolution has increased, the capacity to understand disease mechanisms has advanced for all major blinding conditions. In the retina, this has advanced on two parallel fronts, firstly, improved imaging of individual retinal layers including the photoreceptor mosaic, and secondly, improved imaging of retinal vasculature and microvasculature and associated structures. At the forefront of this is the ultra-high resolution provided by adaptive optics techniques, enabling single cell resolution in vivo. To date, th
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
33110000
33000000
33100000
II.2.3) Place of performance
NUTS code:
UKN06
Main site or place of performance:
II.2.4) Description of the procurement
Multiple research groups within QUB are addressing the earliest changes of disease at the complex intersection between normal ageing and early pathology in AMD (Peto, Hogg, Lengyel), Diabetic Retinopathy (Peto, Stitt, Lois, Hogg, Curtis) and Glaucoma (Azuara-Blanco and Hogg), exploring interventions to delay or prevent onset. Cutting edge retinal imaging is crucial to these endeavours. Advanced retinal imaging has been at the forefront of research advances in ophthalmology; as resolution has increased, the capacity to understand disease mechanisms has advanced for all major blinding conditions. In the retina, this has advanced on two parallel fronts, firstly, improved imaging of individual retinal layers including the photoreceptor mosaic, and secondly, improved imaging of retinal vasculature and microvasculature and associated structures. At the forefront of this is the ultra-high resolution provided by adaptive optics techniques, enabling single cell resolution in vivo. To date, these various technologies are available at QUB to support clinical trials on separate instruments, necessitating long tiring visits for patients and challenges for researchers in co-registering the different imaging types to look at the same location simultaneously. In order to address some of the above issues, Queens University wishes to procure a compact, multi-modal and multi-scale retinal imaging system, with microscopic resolution capability that is able to overcome the above-mentioned issues, in combination with laser-based imaging to help with media opacities and provide confocality.The equipment will be installed at The Wellcome Trust-Wolfson Northern Ireland Clinical Research Facility (NICRF), a joint venture between Health and Social Care, Queens University, and the University of Ulster, located in Belfast City Hospital.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 120
This contract is subject to renewal: Yes
Description of renewals:
Option to extend maintenance and the purchase of consumables beyond this period for a further period of up to 10 years or the end of useful life of the equipment.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
Option to extend maintenance and the purchase of consumables beyond this period for a further period of up to 10 years or the end of useful life of the equipment.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
N/A
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
- Accelerated procedure
Justification:
Queen's will be availing of Article 27 (3), Public Contracts Regulations 2015; where a state of urgency duly substantiated by the contracting authority renders impracticable the time limit laid down in the second subparagraph of paragraph 1, it may fix a time limit which shall be not less than 15 days from the date on which the contract notice was sent
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
09/02/2024
Local time: 16:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
09/02/2024
Local time: 16:10
Place:
Belfast
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4) Procedures for review
VI.4.1) Review body
Queens University Belfast
Belfast
UK
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
N/A
VI.5) Date of dispatch of this notice
25/01/2024